Real World Data in Oncology: Third- and Fourth-Line Treatments Administered in Metastatic Colon-Rectal Cancer (MCRC).

@article{Heiman2014RealWD,
  title={Real World Data in Oncology: Third- and Fourth-Line Treatments Administered in Metastatic Colon-Rectal Cancer (MCRC).},
  author={Franca Heiman and Claudio Ripellino and Elena Visentin},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2014},
  volume={17 7},
  pages={A644}
}
oncologists on mCRC patients between March and April 2014 and retrieved from an extra boost of ONCOVIEW database. ONCOVIEW is a continuous syndicated study on cancer treatment in the hospital setting, based on the collection of patient questionnaires. Patients inclusion criteria were the presence of an mCRC diagnosis, 3rd or later actual therapy line and no participation in a phase II or III clinical study. Information collected included patient demographic characteristics, mCRC characteristics… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
0 Citations
1 References
Similar Papers

References

Publications referenced by this paper.

Drug Design, Development and Therapy

  • Ying-dong Cheng
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…